187.94 +0.02 (0.01%)
After hours: 4:23PM EDT
|Bid||180.09 x 800|
|Ask||197.50 x 1400|
|Day's Range||187.02 - 188.87|
|52 Week Range||177.58 - 220.20|
|PE Ratio (TTM)||295.94|
|Earnings Date||Oct 23, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||205.79|
As the following stock charts of Nektar Therapeutics (NASDAQ:NKTR), Waters (NYSE:WAT) and A.O. Smith (NYSE:AOS) indicate, some stocks are still well-positioned to move higher. Nektar Therapeutics, though, is an exception to that rule of thumb. • A careful look at the daily chart also makes clear that Nektar Therapeutics shares found support at key short-term moving average lines, which is where you’d expect/want to find support.
hit their lowest point since 1996 after questions about the retailer’s valuation, already under pressure due to fierce competition in the sector, increased concerns about its debt levels. Analysts at Bernstein warned on Wednesday that investors should be paying close attention to Casino’s related party transactions involving mainly French franchisees. Casino shares dropped as much as 10 per cent in response while shares in its parent company Rallye were down close to 8 per cent at one point as investors digested what a fall in valuation might mean for the heavily indebted group.
UNIFI’s Application Programming Interface Pairs with Leading MS Metabolite Identification Processing Software/Platform
Waters (WAT) delivered earnings and revenue surprises of 1.56% and -0.30%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
The Milford, Massachusetts-based company said it had profit of $1.98 per share. Earnings, adjusted for one-time gains and costs, were $1.95 per share. The results exceeded Wall Street expectations. The ...
MILFORD, Mass.-- -- Sales of $596 million grew 7% as reported and 5% in constant currency Growth across all end markets with strong TA performance Strong growth from China, partially offset by softness in the U.S. GAAP EPS increased 21% to $1.98; non-GAAP EPS increased 11% to $1.95 Waters Corporation today announced second quarter 2018 sales of $596 million, a 7% increase as reported, versus sales ...
Waters Corp (WAT) is scheduled to report second-quarter results which are likely to be driven by its strong position in the pharmaceutical market and robust mass spectrometry portfolio.
Desorption Electrospray Ionization (DESI) Imaging Technology Enables Analysis of Spatial Distribution of Molecules in Tissue, and thus Deeper Biological Insights. Today, Waters Corporation (WAT), Prosolia, Inc. and the Purdue Research Foundation (PRF) announced that Waters® acquired exclusive rights to Desorption Electrospray Ionization (DESI) technology for all mass spectrometry applications from Prosolia and PRF.
There are better alternatives to Waters Corporation (NYSE: WAT ) in the life sciences tools sector from the perspective of acceleration in organic growth, according to an analyst at Janney. The Analyst ...
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding WAT totaled $1.19 billion.
LONDON, UK / ACCESSWIRE / July 12, 2018 / If you want a free Stock Review on TRXC sign up now at www.wallstequities.com/registration. WallStEquities.com takes a close look at four Medical Instruments and Supplies stocks, particularly, Tandem Diabetes Care Inc. (NASDAQ: TNDM), The Cooper Cos. Inc. (NYSE: COO), TransEnterix Inc. (NYSE American: TRXC), and Waters Corp. (NYSE: WAT).
Waters Corporation will webcast its Q2 2018 financial results conference call live on Tuesday, July 24th at 8:00 a.m. eastern time. To listen to the conference call connect to Waters’ website, www.waters.com choose “Investors” and click on the Live Webcast.
This article is a part of InvestorPlace’s Best ETFs for 2018 contest. James Brumley’s pick for the contest is Powershares Water Resource Portfolio (NASDAQ:PHO). As far as investment returns go, my 2018 ETF pick of Invesco Water Resources ETF (NASDAQ:PHO) has been less than thrilling.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding WAT totaled $485 million.
Let’s talk about the popular Waters Corporation (NYSE:WAT). The company’s shares received a lot of attention from a substantial price movement on the NYSE over the last few months, increasingRead More...